M
Maxime Dougados
Researcher at University of Paris
Publications - 1144
Citations - 78022
Maxime Dougados is an academic researcher from University of Paris. The author has contributed to research in topics: Rheumatoid arthritis & Ankylosing spondylitis. The author has an hindex of 134, co-authored 1054 publications receiving 69979 citations. Previous affiliations of Maxime Dougados include French Institute of Health and Medical Research & Paris Descartes University.
Papers
More filters
Journal ArticleDOI
Differences Between Women and Men With Recent-Onset Axial Spondyloarthritis: Results From a Prospective Multicenter French Cohort
Anne Tournadre,Bruno Pereira,A. Lhoste,J.-J. Dubost,J.M. Ristori,Pascal Claudepierre,Maxime Dougados,Martin Soubrier +7 more
TL;DR: To clarify sex differences in early axial spondyloarthritis (SpA), a large number of patients with SpA are diagnosed with atypical central giant cell granuloma, a leading complication of multiple sclerosis.
Journal ArticleDOI
Molecular markers of cartilage breakdown and synovitis at baseline as predictors of structural progression of hip osteoarthritis. The ECHODIAH Cohort
Bernard Mazières,Patrick Garnero,Alice Guéguen,Michel Abbal,L. Berdah,Michel Lequesne,M. Nguyen,Jean-Pierre Salles,Eric Vignon,Maxime Dougados +9 more
TL;DR: Combined measurements of uCTX-II and sHA were a new predictor of the structural progression of hip OA, and grouped survival analysis performed with time to structural progression as dependent variable.
Journal ArticleDOI
The burden of non-radiographic axial spondyloarthritis
Annelies Boonen,Joachim Sieper,Désirée van der Heijde,Maxime Dougados,Jack F. Bukowski,Satish Valluri,Bonnie Vlahos,Sameer Kotak +7 more
TL;DR: Although patients with non-radiographic axSpA have shorter disease duration and lack radiological changes, they demonstrate a substantial burden of illness, with self-reported disease activity and functional impairments comparable to those found in patients with radiographic disease.
Journal Article
Minimal clinically important difference, low disease activity state, and patient acceptable symptom state: methodological issues.
TL;DR: Threshold values for the MCID and LDAS should be determined according to data-driven and experts' opinions and approaches, and methods to determine the thresholds must be standardized and recommendations could be endorsed by an OMERACT module.
Journal ArticleDOI
Management of osteoarthritis (OA) with an unsupervised home based exercise programme and/or patient administered assessment tools. A cluster randomised controlled trial with a 2x2 factorial design
P. Ravaud,Bruno Giraudeau,Isabelle Logeart,J S Larguier,D Rolland,R Treves,Liana Euller-Ziegler,Bernard Bannwarth,Maxime Dougados +8 more
TL;DR: Although patients' assessments favoured the exercise programme, results from this study failed to demonstrate a short term symptomatic effect of the two non-pharmacological treatments (weekly recording of condition and exercise) in patients with OA concurrently receiving nonsteroidal anti-inflammatory drugs.